| Results summary | View all lists in L2L MDB | View all genes in R05DB.profile.u50 |
|
Up-regulated at least 1.4-fold following treatment of HepG2 human hepatocellular carcinoma cells with carcinogen benzo(a)pyrene (BaP), at any time point from 6-48 hours and at any concentration from 0.25-5 microM. enrichment: 9.75-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 201631_S_AT | IER3 | G | immediate early response 3 | ||||||||||
| 205032_AT | ITGA2 | D | X | C | S | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | |||||||